NCT05986825

Brief Summary

Validation of the French Version of the Score on Quality of Life in Hidradenitis Suppurativa. The French HiSQOL will be completed by 60 patients with hidradenitis suppurativa a first time, and a second time 1 week later.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 3, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

August 14, 2023

Completed
15 days until next milestone

Study Start

First participant enrolled

August 29, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 22, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 22, 2023

Completed
Last Updated

July 23, 2024

Status Verified

August 1, 2023

Enrollment Period

4 months

First QC Date

August 3, 2023

Last Update Submit

July 22, 2024

Conditions

Hidradenitis Suppurativa

Outcome Measures

Primary Outcomes (1)

  • Validation of the questionnaire

    During the visit and 1 week later

Study Arms (1)

Experimental

Patients with Verneuil disease

Other: Verneuil questionnaire Validation

Interventions

Verneuil questionnaire ValidationOTHER

Request patient to Complete the questionnaire for validation of the French version

Experimental

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with Verneuil disease

You may qualify if:

  • Age ≥18 years
  • Patient with Verneuil disease
  • Beneficiary of or affiliated to a social security insurance
  • Participation agreement

You may not qualify if:

  • Patients physically or mentally unable to complete questionnaires.
  • Refusal to participate
  • Patient under legal protection (guardianship, curatorship) or deprived of liberty

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Brest

Brest, 29200, France

Location

MeSH Terms

Conditions

Hidradenitis Suppurativa

Condition Hierarchy (Ancestors)

Skin Diseases, BacterialBacterial InfectionsBacterial Infections and MycosesInfectionsSkin Diseases, InfectiousSuppurationSkin DiseasesSkin and Connective Tissue DiseasesHidradenitisSweat Gland Diseases

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 3, 2023

First Posted

August 14, 2023

Study Start

August 29, 2023

Primary Completion

December 22, 2023

Study Completion

December 22, 2023

Last Updated

July 23, 2024

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will share

All collected data that underlie results in a publication

Shared Documents
STUDY PROTOCOL
Time Frame
All collected data that underlie results in a publication
Access Criteria
Data access requests will be reviewed by the internal committee of Brest UH. Requestors will be required to sign and complete a data access agreement.

Locations

FR(1)